BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 38259499)

  • 1. Astrocytes in fragile X syndrome.
    Talvio K; Castrén ML
    Front Cell Neurosci; 2023; 17():1322541. PubMed ID: 38259499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
    Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
    J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte-secreted thrombospondin-1 modulates synapse and spine defects in the fragile X mouse model.
    Cheng C; Lau SK; Doering LC
    Mol Brain; 2016 Aug; 9(1):74. PubMed ID: 27485117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase plasminogen activator mediates changes in human astrocytes modeling fragile X syndrome.
    Peteri UK; Pitkonen J; de Toma I; Nieminen O; Utami KH; Strandin TM; Corcoran P; Roybon L; Vaheri A; Ethell I; Casarotto P; Pouladi MA; Castrén ML
    Glia; 2021 Dec; 69(12):2947-2962. PubMed ID: 34427356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An iPSC-derived astrocyte model of fragile X syndrome exhibits dysregulated cholesterol homeostasis.
    Talvio K; Wagner VA; Minkeviciene R; Kirkwood JS; Kulinich AO; Umemori J; Bhatia A; Hur M; Käkelä R; Ethell IM; Castrén ML
    Commun Biol; 2023 Jul; 6(1):789. PubMed ID: 37516746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome.
    Jawaid S; Kidd GJ; Wang J; Swetlik C; Dutta R; Trapp BD
    Glia; 2018 Apr; 66(4):789-800. PubMed ID: 29274095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directly reprogrammed fragile X syndrome dorsal forebrain precursor cells generate cortical neurons exhibiting impaired neuronal maturation.
    Edwards N; Combrinck C; McCaughey-Chapman A; Connor B
    Front Cell Neurosci; 2023; 17():1254412. PubMed ID: 37810261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated cholesterol metabolism, aberrant excitability and altered cell cycle of astrocytes in fragile X syndrome.
    Ren B; Burkovetskaya M; Jung Y; Bergdolt L; Totusek S; Martinez-Cerdeno V; Stauch K; Korade Z; Dunaevsky A
    Glia; 2023 May; 71(5):1176-1196. PubMed ID: 36594399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocyte-mediated purinergic signaling is upregulated in a mouse model of Fragile X syndrome.
    Reynolds KE; Wong CR; Scott AL
    Glia; 2021 Jul; 69(7):1816-1832. PubMed ID: 33754385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed Maturation of Fast-Spiking Interneurons Is Rectified by Activation of the TrkB Receptor in the Mouse Model of Fragile X Syndrome.
    Nomura T; Musial TF; Marshall JJ; Zhu Y; Remmers CL; Xu J; Nicholson DA; Contractor A
    J Neurosci; 2017 Nov; 37(47):11298-11310. PubMed ID: 29038238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
    PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte-mediated disruption of ROS homeostasis in Fragile X mouse model.
    Vandenberg GG; Dawson NJ; Head A; Scott GR; Scott AL
    Neurochem Int; 2021 Jun; 146():105036. PubMed ID: 33785420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Audiogenic Seizures in the
    Gonzalez D; Tomasek M; Hays S; Sridhar V; Ammanuel S; Chang CW; Pawlowski K; Huber KM; Gibson JR
    J Neurosci; 2019 Dec; 39(49):9852-9863. PubMed ID: 31666356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fragile X mutation impairs homeostatic plasticity in human neurons by blocking synaptic retinoic acid signaling.
    Zhang Z; Marro SG; Zhang Y; Arendt KL; Patzke C; Zhou B; Fair T; Yang N; Südhof TC; Wernig M; Chen L
    Sci Transl Med; 2018 Aug; 10(452):. PubMed ID: 30068571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial bioenergetics of astrocytes in Fragile X syndrome: new perspectives on culture conditions and sex effects.
    Vandenberg GG; Thotakura A; Scott AL
    Am J Physiol Cell Physiol; 2022 Feb; 322(2):C125-C135. PubMed ID: 34817267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocytic Contributions to Synaptic and Learning Abnormalities in a Mouse Model of Fragile X Syndrome.
    Hodges JL; Yu X; Gilmore A; Bennett H; Tjia M; Perna JF; Chen CC; Li X; Lu J; Zuo Y
    Biol Psychiatry; 2017 Jul; 82(2):139-149. PubMed ID: 27865451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms of Synaptic Dysregulation in Fragile X Syndrome and Autism Spectrum Disorders.
    Telias M
    Front Mol Neurosci; 2019; 12():51. PubMed ID: 30899214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF in fragile X syndrome.
    Castrén ML; Castrén E
    Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of IL-6 Secretion by Astrocytes via TLR4 in the Fragile X Mouse Model.
    Krasovska V; Doering LC
    Front Mol Neurosci; 2018; 11():272. PubMed ID: 30123107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of GluN2A NMDA receptors ameliorates synaptic plasticity deficits in the Fmr1
    Lundbye CJ; Toft AKH; Banke TG
    J Physiol; 2018 Oct; 596(20):5017-5031. PubMed ID: 30132892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.